"To localize the monoclonal antibody would exclude it from working on cancer cell metastasis. It would also most likely kill the ease of use, and the nice story would fade away, with the stock price not far behind.
Not so Impeccable lines of thought."
Hasn't much of the disucssion around Bavi suggested that its efficacy would be enhanced by combination therapies? Therefore, the metastasis of cancer cells could be addressed by such therapies as chemotherapy and radiation, as they are presently?
News 
Market Data 
Discover 
AI
